SCHEMBL204034

SCHEMBL204034

CC(C)N(C(C)C)P(OCCC#N)N(C(C)C)C(C)C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.32
NLRP3 Q96P20 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29674430 0.98 TSHR (0.31) TSHRNLRP3
SCHEMBL20211370 0.98 TSHR (0.31) TSHRNLRP3
Ammonia Solution, Strong SCHEMBL21828798 0.98 TSHR (0.31) TSHRNLRP3
SCHEMBL24487862 0.91
SCHEMBL30389839 0.90 TSHR (0.34) TSHRNLRP3
SCHEMBL22765087 0.89
SCHEMBL10169834 0.89
SCHEMBL24778743 0.88
SCHEMBL20909620 0.86
SCHEMBL12134556 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3605 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119751529-B Nucleotide dimer, preparation method and application thereof Beijing Xuanjingrui Pharmaceutical Technology Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-122005503-A Ultrasonic response apoptosis bionic targeting nano-carrier delivery material and preparation method thereof 暨南大学 2026-05-12 CN claimed
EP-3972984-B1 PROCESS FOR THE PREPARATION OF GALNAC PHOSPHORAMIDITE EPIMERS HOFFMANN LA ROCHE (CH) 2026-03-04 EP claimed
US-20250368998-A1 NUCLEOTIDE ANALOGUES, AND PREPARATION AND APPLICATION THEREOF HITGEN INC (CN) 2025-12-04 US claimed
US-20250320244-A1 Click-Labeled Nucleosides and Phosphoramidites SOMALOGIC OPERATING CO., INC. (US) 2025-10-16 US claimed
US-20250313590-A1 Phosphoramidite morpholino monomers towards synthesis/convergent synthesis of PMO, TMO, their chimera oligos in 5 prime to 3 prime direction INDIAN ASSOCIATION FOR THE CULTIVATION OF SCIENCE (IACS) (IN) 2025-10-09 US claimed
US-20250289843-A1 PROCESS FOR PREPARATION OF TARGETING LIGANDS SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT 2025-09-18 US claimed
US-20250289842-A1 Processes for Making NAG-25, a Carbohydrate Targeting Moiety, and its Intermediates AMGEN INC. 2025-09-18 US claimed
US-20250243485-A1 Targeting Ligands For Therapeutic Compounds Arrowhead Pharmaceuticals, Inc. 2025-07-31 US claimed
EP-4587448-A1 CLICK-LABELED NUCLEOSIDES AND PHOSPHORAMIDITES SomaLogic Operating Co., Inc. (US) 2025-07-23 EP claimed
US-6894158-B2 Methods of producing phosphitylated compounds HONEYWELL INTERNATIONAL INC. (US) 2005-05-17 US claimed
EP-1476407-A2 METHODS OF PRODUCING PHOSPHITYLATED COMPOUNDS Honeywell International Inc. (US) 2004-11-17 EP claimed
US-20040110308-A1 Anthraquinone quencher dyes, their methods of preparation and use INTEGRATED DNA TECHNOLOGIES, INC. (US) 2004-06-10 US claimed
WO-2004035599-A1 PHOSPHITYLATION PROCESS AVECIA BIOTECHNOLOGY INC. (US) 2004-04-29 WO claimed
US-20030232980-A1 Methods of producing phosphitylated compounds HONEYWELL INTERNATIONAL INC. 2003-12-18 US claimed
US-20030191304-A1 Activators for oligonucleotide synthesis IONIS PHARMACEUTICALS, INC. 2003-10-09 US claimed
WO-2003072586-A2 METHODS OF PRODUCING PHOSPHITYLATED COMPOUNDS HONEYWELL INTERNATIONAL INC. (US) 2003-09-04 WO claimed
US-6274725-B1 PROVIDING COMPOUND HAVING A HYDROXYL GROUP; REACTING WITH PHOSPHITYLATING REAGENT IN THE PRESENCE OF A PYRIDINUM SALT IN A SOLVENT UNDER CONDITIONS OF TIME, TEMPERATURE AND PRESSURE TO YIELD PHOSPHITYLATED COMPOUND ISIS PHARMACEUTICALS, INC. 2001-08-14 US claimed
US-6172209-B1 MOLECULAR HYBRIDIZATION, GENETIC ENGINEERING; NUCLEASE RESISTANCE ISIS PHARMACEUTICALS INC. 2001-01-09 US claimed
WO-1998016540-A1 IMPROVED COUPLING ACTIVATORS FOR OLIGONUCLEOTIDE SYNTHESIS PROLIGO LLC (US) 1998-04-23 WO claimed